TC-2696

DB05576ExperimentalSmall molecule

Investigated for use/treatment in pain (acute or chronic).

Chemical structure of TC-2696
Primary indication
Investigated for use/treatment in pain (acute or chronic).Curator reviewed
Formula / weight
C12H18N2O ยท 206.289 g/mol (avg)
Also known as
5-(5-METHOXY-3-PYRIDINYL)-N-METHYL-4-PENTEN-2-AMINE, (2S,4E)-
Code names
TC-2696

Resolves to

Compound
UNII2984M6L5QVCAS552302-36-0ChEMBLCHEMBL269954
Structure
InChIKeyHXZJTUDXVFHWOB-RWCYGVJQSA-NSMILESCN[C@@H](C)C\C=C\C1=CC(OC)=CN=C1

Which companies are running trials of TC-2696, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In